Introduction
It has been known since ancient times that physical exercise helps to maintain a healthy body. Recently, it has been increasingly acknowledged that this holds true for the brain as well, i.e. physical activity directly promotes cognitive function and brain health by mechanisms that include the induction of neurotrophins such as BDNF and IGF-1, increased angiogenesis and neurogenesis (for review see Lista and Sorrentino, 2010; van Praag, 2009) . Common wisdom tells 0925-4773/$ -see front matter Ó 2012 Elsevier Ireland Ltd. All rights reserved. http://dx.doi.org/10.1016/j.mod.2012.09.008 us, however, that not only physical activity, but also mental exercise helps to maintain a healthy brain. Research over the last two decades has confirmed this notion and has unraveled the molecular mechanisms that explain why an active brain lives longer. In this review we briefly summarize this research. First, we define the concept of acquired neuroprotection. We then describe the underlying mechanisms that couple synaptic activity to enhanced robustness of neuronal cells. Finally, we propose a model that integrates our current knowledge of acquired neuroprotection and provides a mechanistic framework for future studies.
The concept of acquired neuroprotection
Neurons depend on synaptic activity for their survival. First evidence for this phenomenon came from denervation experiments in sensory systems. For example, lesioning of the olfactory bulb leads to transneuronal degeneration of pyramidal neurons in the piriform cortex (Heimer and Kalil, 1978) . Similarly, in the auditory system, ablation of the cochlea or transection of the eighth nerve causes neuronal cell death in the cochlear nucleus or nucleus magnocellularis in mammals or chick, respectively (Born and Rubel, 1985; Powell and Erulkar, 1962) . Silencing neurons by injection of tetrodotoxin into the auditory nerve mimics the effect of cochlea ablation (Born and Rubel, 1988) . This indicates that denervated neurons die because of a lack of afferent activity. Blockade of synaptic transmission in a variety of peripheral and central neuronal cell types both in vivo and in vitro further demonstrated the requirement for synaptic activity for the survival of developing neurons (Catsicas et al., 1992; Fishbein and Segal, 2007; Lipton, 1986; Maderdrut et al., 1988) . Several studies have shown that ongoing synaptic activity promotes neuronal survival by a mechanism that involves N-methyl-D-aspartate (NMDA)-type ionotropic glutamate receptors, calcium influx into neurons, and activation of PI3K/Akt signaling (Collins et al., 1991; Heck et al., 2008; Hegarty et al., 1997; Ikonomidou et al., 1999; Miller et al., 1997; Papadia et al., 2005) . The resulting view from these studies is that basal electrical activity acts to suppress the intrinsic apoptotic machinery, thereby ensuring the survival of those neurons that are well integrated into synaptic networks. This appears to be especially important during the development of neuronal circuits. While basal activity is sufficient to keep neurons alive under physiological conditions, it still leaves them highly vulnerable to cellular stress. In contrast, enhanced neuronal activity leads to the build-up of a protective shield against harmful conditions. For example, placing rats into an enriched environment, and thus increasing neuronal activity in vivo, leads to protection against brain damage caused by kainate-induced seizures (Young et al., 1999) . Similarly, increasing synaptic activity in cultured neurons by inducing action potential (AP) bursting renders neurons resistant to various harmful conditions including glutamate excitotoxicity, trophic deprivation, and treatment with chemical inducers of apoptosis including staurosporine, okadaic acid, C-2 ceramide, and retinoic acid (Hardingham et al., 2002; Lee et al., 2005; Papadia et al., 2005; Soriano et al., 2006) . This effect, which has been termed 'acquired neuroprotection', depends on gene transcription, takes several hours to be implemented and lasts for up to several days after its initiation. Thus, acquired neuroprotection is distinct from survival afforded by basal synaptic activity; it is defined as an increased and long-lasting robustness against diverse cellular stresses induced by episodes of enhanced synaptic activity.
3.
Molecular mechanisms of acquired neuroprotection 3.1.
Enhanced synaptic activity turns on a genomic prosurvival program
The build-up of acquired neuroprotection is a transcription-dependent process. Thus, to achieve its full neuroprotective effect, enhanced synaptic activity needs to be translated into changes in gene expression. How is this achieved? The signaling mechanisms that link synaptic activity to the regulation of gene transcription in neurons have been studied extensively and have been covered comprehensively in several recent reviews (Bengtson and Bading, 2012; Greer and Greenberg, 2008; Hagenston and Bading, 2011; Mellstrom et al., 2008) . Due to space limitations we will focus on two major mechanisms that work together to alter neuronal gene expression in response to synaptic activity.
Nuclear calcium-dependent gene transcription
It is now well established that calcium signaling plays a central role in activity-dependent gene transcription. A major route of synapse-to-nucleus communication is initiated by influx of calcium through synaptic NMDA receptors (NMDARs); this can lead to intracellular calcium transients that invade the nucleus to activate calcium-dependent transcription factors such as CREB and MEF2. Genome-wide expression studies revealed that signaling via synaptic NMDARs and nuclear calcium drives the expression of a comprehensive genomic pro-survival program (Zhang et al., 2007) . Zhang et al. (2009) found that AP bursting in cultured hippocampal neurons regulates the expression of 431 genes and of those 185 depend on nuclear calcium signaling. From the list of nuclear calcium dependent genes, a core set of pro-survival factors, termed Activity-regulated Inhibitors of Death (AID) genes, was identified. These genes comprise Atf3, Btg2, GADD45b, GADD45c, Inhibin b-A, Interferon activated gene 202B, Npas4, Nr4a1, and Serpinb2. The central role of these genes was established by demonstrating that overexpression of individual AID genes is neuroprotective both in vitro and in vivo. Several AID genes are transcription factors that further contribute to activity-induced changes in gene expression by regulating down-stream targets.
Activity-dependent nucleo-cytoplasmic shuttling
Besides calcium-dependent activation of transcription factors, additional mechanisms participate in shaping the genomic response to survival-promoting synaptic activity. One of these mechanisms is activity-dependent nucleo-cytoplasmic shuttling of transcriptional regulators. FoxO3a, a member of the forkhead transcription factor family, usually acts to con-vey cell death stimuli by activating the transcription of pro-apoptotic genes including Fas-L, Bim, and TRAIL. The activity of FoxO3a is predominantly controlled by its subcellular localization. Under physiological conditions FoxO3a is kept in the cytoplasm, whereas cellular stress leads to its nuclear import (Brunet et al., 1999) . AP bursting leads to nuclear calcium-dependent phosphorylation of FoxO3a and subsequent nuclear export of this pro-death transcription factor (Dick and Bading, 2010) . Moreover, after an episode of enhanced electrical activity, FoxO3a remains excluded from the nucleus even in the presence of pro-death stimuli. Thus, in addition to enhancing the expression of pro-survival genes, synaptic activity also decreases the expression of pro-death genes. Another mechanism through which synaptic activity controls genomic responses involves acetylation and deacetylation of histones. Acetylation of histones by histone acetyl transferases (HATs) renders chromatin permissive for transcription whereas deacetylation by histone deacetylases (HDACs) opposes this effect. Sustained AP bursting leads to nuclear export of HDACs, rendering the overall chromatin structure more permissive for CREB-dependent transcription and facilitating the activation of the genomic pro-survival program (Chawla et al., 2003) . In summary, enhanced neuronal activity affects the regulation of gene expression at several levels, resulting in wide-spread and comprehensive changes in a neuron's gene expression profile.
Acquired neuroprotection works by maintaining mitochondrial integrity
How can a change in neuronal gene expression confer robustness against cellular stresses? Depending on the type of insult and on the physiological state of the cell, neurons can undergo different forms of programmed cell death (PCD), including apoptosis, autophagy, and programmed necrosis (Kroemer et al., 2009) . It is now well established that mitochondrial dysfunction is central to all of these three forms of PCD (Nagley et al., 2010; Nunnari and Suomalainen, 2012) . Loss of mitochondrial integrity is detrimental for neurons for several reasons. First, mitochondria are the site of initiation of the intrinsic apoptotic response to cell damage. By activating the pro-death protein PUMA, apoptotic stimuli initiate the formation of pores in the outer mitochondrial membrane (OMM). OMM permeabilisation then leads to release of apoptogenic molecules, most notably cytochrome c and apoptosis inducing factor (AIF), into the cytosol. This leads to assembly of the so-called apoptosome that contains the proteins Apaf1 and caspase 9. Finally, caspase 9 activates downstream caspases to execute apoptotic cell death. Second, calcium overload and other stresses lead to opening of mitochondrial permeability transition pores (MPTPs) in the inner mitochondrial membrane. Permeability transition leads to the dissipation of the transmembrane proton gradient and thus to a breakdown of the mitochondrial membrane potential. This results in a loss of mitochondrial respiratory chain function and ATP production, ultimately leading to the depletion of energy from the cell. Third, opening of MPTPs and respiratory chain dysfunction lead to excessive production of reactive oxygen species (ROS) that cause oxidative damage to proteins, lipids, and DNA (Adam-Vizi and Starkov, 2010). Excessive oxidative stress ultimately causes cell death.
Given this crucial role of mitochondria in cell death, it is perhaps not surprising that acquired neuroprotection acts via several mechanisms that impinge on preserving mitochondrial integrity. First, the activity-induced pro-survival transcriptional responses include the downregulation of PUMA, the prime initiator of OMM permeabilisation Leveille et al., 2010) . In addition, several downstream pro-apoptotic proteins, including Apaf1, caspase 9, caspase 3, FLASH, and Tia1, are also downregulated by prolonged AP bursting Leveille et al., 2010; Zhang et al., 2007) . Second, enhanced neuronal activity inhibits stress-induced mitochondrial permeability transition and mitochondrial membrane potential breakdown Zhang et al., 2007 Zhang et al., , 2009 ). This finding can likely be explained, in part, by the activity-dependent downregulation of the pro-apoptotic protein p53 which has recently been shown to be a regulator of MPTP opening Vaseva et al., 2012) . Third, the activity-induced transcriptional responses include coordinate changes to the cellintrinsic antioxidant machinery, combating the deleterious effects of excess ROS generation. For example, AP bursting leads, in a nuclear calcium dependent manner, to transcriptional upregulation of two potent antioxidant enzymes, sulfiredoxin (Srxn1) and sestrin 2 (Sesn2) (Papadia et al., 2008; Zhang et al., 2009 ). In addition, AP bursting enhances the activity of the antioxidant enzyme, thioredoxin, by transcriptional downregulation of its endogenous inhibitor, TXNIP (Papadia et al., 2008) .
In summary, acquired neuroprotection appears to mainly work by preserving mitochondrial integrity and by counteracting several events that are immediately downstream to mitochondrial dysfunction. Thus, effector mechanisms of acquired neuroprotection predominantly interfere with the initiation, rather than the execution, of cell death.
4.
The divergence-convergence model of acquired neuroprotection
When considering the signaling cascade that translates synaptic activity into a cellular state of acquired neuroprotection, it appears that a single stimulus diverges, via several signaling mechanisms, into a broad transcriptional response that then, at the functional level, converges to the stabilization of one major cellular target (Fig. 1a) . In the divergenceconvergence signaling model, sustained activation of synaptic NMDA receptors acts as the stimulus that induces calcium-dependent activation of a handful of transcriptional regulators ('first order transcription factors (TFs)' such as CREB and MEF2). The resulting upregulation of AID transcription factors ('second order TFs') causes a second wave of gene expression changes that culminates in the differential expression of hundreds of genes. The experimental evidence available so far suggests that this comprehensive genomic response translates into the build-up of acquired neuroprotection predominantly (although not exclusively) via one mechanism, which is the maintenance of mitochondrial integrity. What could be the advantage of introducing such a tremendous signaling divergence between NMDAR activation and mitochondrial protection? It appears that a more straightforward signaling cascade would be more economical (Fig. 1b) . However, the divergence-convergence mode of signaling may confer a high degree of robustness to the system. In general, more complex signaling networks are believed to better guarantee proper function in the face of external or internal perturbations (Stelling et al., 2004) . Given that dead neurons usually cannot be replaced in the mature brain, it is of vital importance for the organism to reliably build-up and maintain a neuroprotective shield. A robust signaling network might buffer external perturbations like, e.g., transient fluctuations in synaptic activity levels. In addition, a robust and redundant network can maintain its function even if, as an example of an internal perturbation, individual components are mutated or lost during evolution, development, or ageing. Moreover, cellular signaling is based on inherently 'noisy' biochemical processes that are subject to random variation (Eldar and Elowitz, 2010; Ladbury and Arold, 2012) . Here, a redundant network would confer robustness by ensuring reliable activation of the neuroprotective machinery despite the stochastic nature of the underlying individual biochemical interactions.
The divergent architecture of its signaling network might also help explain another salient feature of acquired neuroprotection, namely its relative longevity. As mentioned above, neurons remain in a protected state for several days after an episode of enhanced electrical activity has ended. Thus, mechanisms need to exist that preserve and reinforce the internal signal long after the external trigger has been removed. The levels of first and second order TF activation peak at around 2 h and 4-6 h, respectively, after the onset of enhanced activity, returning close to baseline soon thereafter. Thus, the 'memory' of a neuron's activity history seems to be embedded downstream of these TFs, most likely in the large network of activity-regulated genes. Indeed, this large network may provide sufficient signaling space for intricate feedback loops that would help maintain an activated state for prolonged times. Theoretical studies suggest certain design rules for feedback loops that can promote slow turn-off rates of activated systems (Mitrophanov and Groisman, 2008; Shi et al., 2012) . Further experimental work is required to better characterize the signaling network of acquired neuroprotection, and to test if it indeed contains the here proposed feedback loops.
Several of the above considerations are based on the assumption that the acquired neuroprotection signaling network contains a high degree of redundancy. So how redundant is the gene network? Recent experiments provided some first insight. Overexpression of individual AID genes confers a state of acquired neuroprotection to cells both in vitro and in vivo (Zhang et al., 2009 (Zhang et al., , 2011 . AID genes, if they are transcriptional regulators, regulate each a small, largely non-overlapping subset of activity-dependent genes (Bas Orth C., Tan Y., Bading H. unpublished observations). Thus, activation of a subset of the gene network is sufficient to induce acquired neuroprotection, which is in agreement with a profound degree of functional redundancy of the network (Fig. 1c) . This finding then implies that, conversely, inactivation of a subset of the network would not compromise the build-up of acquired neuroprotection (Fig. 1d) . However, some experimental evidence seems inconsistent with this view. For example, shRNA-mediated knock-down of individual AID genes, Btg2 or Bcl6, has been shown to prevent the build-up of acquired neuroprotection (Zhang et al., 2007) . There is, however, a possible explanation that could reconcile this finding with the concept. In the knock-down experiments the transcriptional regulators Btg2 and Bcl6 were inactivated several days before acquired neuroprotection was induced by AP bursting. Thus, before the onset of the actual experiment, widespread changes in transcription probably had occurred. This would result in a more vulnerable condition of the neurons that cannot be rescued by synaptic activity any longer. Importantly, there is a fundamental difference between chronically removing a pro-survival transcriptional regulator from the system and preventing its stimulus-induced upregulation. A more conclusive experiment would thus require the acute block of activity-mediated upregulation of individual AID genes. Another explanation of the knock-down results would be that some of the AID genes might indeed by critical signaling hubs within the gene network that are indispensible for proper build-up of acquired neuroprotection. It is thus possible that redundancy is limited and that some components of the network might be more important than others. Ideally, careful analysis of acute gain-of-function and lossof-function experiments for all individual components will ultimately reveal the design rules of the signaling network that underlies the build-up and maintenance of acquired neuroprotection.
